Trials / Completed
CompletedNCT00311389
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 408 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the intraocular pressure(IOP)-lowering efficacy of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution | Investigational ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension |
| DRUG | Latanoprost 0.005%/Timolol 0.005% ophthalmic solution | Commercially marketed ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2004-09-01
- Completion
- 2004-09-01
- First posted
- 2006-04-06
- Last updated
- 2012-02-14
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00311389. Inclusion in this directory is not an endorsement.